New assay may help predict which pancreatic lesions may become cancerous
A report describes a new simple molecular test to detect chromosomal abnormalities — biomarkers known as telomere fusions–in pancreatic tumour specimens and pancreatic cyst fluids. This assay may help predict the presence of high-grade or invasive pancreatic cancers requiring surgical intervention.More sophisticated imaging of the pancreas has led to increased detection of presymptomatic lesions. The […]
